The effects of anti-depressants on depression symptom scores at 12 months follow-up in patients with cardiometabolic disease: results from a large primary care cohort

Jani, B. D. , Purves, D., Barry, S. J.E. , Mccowan, C. , Cavanagh, J. and Mair, F. S. (2015) The effects of anti-depressants on depression symptom scores at 12 months follow-up in patients with cardiometabolic disease: results from a large primary care cohort. Journal of Family Medicine and Primary Care, 4(3), pp. 373-379. (doi:10.4103/2249-4863.161324)

[img]
Preview
Text
108236.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.

1MB

Abstract

Background: Evidence on the long-term usefulness of anti-depressants in managing depression in cardiometabolic disease is limited. Aim: We examined the effects of anti-depressant prescribing on depressive symptoms at 12 months follow-up in patients with cardiometabolic disease and a positive depression screening result at baseline. Design and setting: We retrospectively reviewed routine UK primary care data for patients with coronary heart disease, diabetes and previous stroke for the year 2008-2009. 35,537 patients with one of the three above diseases underwent depression screening using the Hospital Anxiety and Depression Scale (HADS-D). Of 7080 patients with a positive screening result (HADS-D ≥ 8), 3933 (55.5%) patients had a repeat HADS-D recorded at 12 months follow-up. Methods: We compared the change in HADS-D at follow-up and remission rate in those who were prescribed anti-depressants (n = 223) against those who were not (n = 3710). Results: The mean change in HADS-D from baseline, for the nonprescribed group was similar to the reduction observed in patients who were continuously prescribed (n = 93) with anti-depressants during follow-up. Patients who were prescribed intermittently (n = 72) or only one (n = 58) prescription during follow-up had a lower reduction in HADS-D compared to the nonprescribed group. There was no difference in remission rates between continuously prescribed and the nonprescribed group, but remission was lower in patients prescribed intermittently and single prescription. Conclusion: Improvement in depressive symptoms in patients with cardiometabolic disease at 12 months was not any better in patients prescribed with anti-depressants compared to the nonprescribed group. The role of anti-depressants in the management of depression in cardiometabolic disease merits further investigation.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Cavanagh, Professor Jonathan and Jani, Dr Bhautesh and Mccowan, Professor Colin and Barry, Dr Sarah and Mair, Professor Frances and Purves, Mr David
Authors: Jani, B. D., Purves, D., Barry, S. J.E., Mccowan, C., Cavanagh, J., and Mair, F. S.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Robertson Centre
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Mental Health and Wellbeing
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > General Practice and Primary Care
Journal Name:Journal of Family Medicine and Primary Care
Publisher:Medknow Publications and Media Pvt. Ltd.
ISSN:2249-4863
ISSN (Online):2249-4863
Copyright Holders:Copyright © 2015 Medknow Publications and Media Pvt. Ltd.
First Published:First published in Journal of Family Medicine and Primary Care 4(3):373-379
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record